In response to the patient's question about how to know whether drugs are safe, the nurse explains that all medications undergo rigorous scientific testing controlled by what organization?

Food and Drug Administration (FDA)

Drug Enforcement Agency (DEA)

Centers for Disease Control and Prevention (CDC)

Joint Commission on Accreditation of Healthcare Organizations (JCAHO)

Answer and Explanation

The Correct Answer is A

A. The FDA is responsible for regulating and ensuring the safety and efficacy of drugs, medical devices, and other health-related products. All medications must undergo rigorous scientific testing and approval processes overseen by the FDA before they can be marketed to the public.
B. The DEA regulates controlled substances and enforces laws related to drug abuse, but it does not control the scientific testing of medications.
C. The CDC focuses on public health and disease prevention, not the regulation or testing of medications.
D. The Joint Commission accredits healthcare organizations but does not directly oversee the scientific testing of medications.

Nursing Test Bank

Quiz #1: RN Exams Pharmacology Exams Quiz #2: RN Exams Medical-Surgical Exams Quiz #3: RN Exams Fundamentals Exams Quiz #4: RN Exams Maternal-Newborn Exams Quiz #5: RN Exams Anatomy and Physiology Exams Quiz #6: RN Exams Obstetrics and Pediatrics Exams Quiz #7: RN Exams Fluid and Electrolytes Exams Quiz #8: RN Exams Community Health Exams Quiz #9: RN Exams Promoting Health across the lifespan Exams Quiz #10: RN Exams Multidimensional care Exams

Get 100+ Naxlex Exit Exams for $79 Try Naxlex NCLEX-RN (14 Day Free-Trial)

Naxlex Comprehensive Predictor Exams

Quiz #1: Naxlex RN Comprehensive online practice 2019 B with NGN Quiz #2: Naxlex RN Comprehensive Predictor 2023 Quiz #3: Naxlex RN Comprehensive Predictor 2023 Exit Exam A Quiz #4: Naxlex HESI Exit LPN Exam Quiz #5: Naxlex PN Comprehensive Predictor PN 2020 Quiz #6: Naxlex VATI PN Comprehensive Predictor 2020 Quiz #8: Naxlex PN Comprehensive Predictor 2023 - Exam 1 Quiz #10: Naxlex HESI PN Exit exam Quiz #11: Naxlex HESI PN EXIT Exam 2

Free Nursing Study Resources

Correct Answer is C

Explanation

A. Capsules generally take longer to dissolve than liquid suspensions and thus do not provide the fastest onset of action.

B. Enteric-coated pills are designed to dissolve in the small intestine rather than the stomach, which can delay the onset of action. They are typically used to protect the drug from stomach acid or to prevent stomach irritation, not for rapid action.

C. Liquid suspensions are absorbed more quickly than solid forms of medication because they do not need to dissolve first, allowing for faster onset of action.

D. Tablets take longer to dissolve than liquid forms and may not provide as rapid an effect as a liquid suspension.

A. Drugs are tested on adults and safe doses for children are based on weights compared to adult weights. B. Drugs are deemed safe for children over time when repeated use proves effectiveness and safety. C. Drugs are tested for both efficacy and safety in children in order to be marketed for pediatric use. D. Drugs are tested on children in post-marketing studies and on a limited basis.

Correct Answer is C

Explanation

A. While pediatric doses are often weight-based, this does not fully account for differences in drug metabolism and effects in children. Pediatric drug safety requires specific testing beyond weight comparisons to adults.

B. Relying on repeated use over time to determine safety is not an evidence-based approach. Drug approval for pediatric use requires formal clinical trials to establish safety and efficacy.

C. The U.S. FDA and other regulatory agencies require that drugs intended for pediatric use undergo clinical trials specifically designed to assess safety, efficacy, and appropriate dosing in children. This ensures that medications are appropriately tested before being marketed for pediatric patients.

D. While some post-marketing studies may include children, initial approval for pediatric use requires pre-market clinical testing. Relying solely on post-marketing studies does not ensure comprehensive safety data before widespread pediatric use.

View Question and Answer

Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.

Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today

In response to the patient's question about how to know whether drugs are safe, the nurse explains that all medications undergo rigorous scientific testing controlled by what organization?

Nursing Test Bank

Naxlex Comprehensive Predictor Exams

The nurse is preparing to administer an oral medication and wants to ensure a rapid drug action. Which form of the medication will the nurse administer?

Correct Answer is C

Explanation

The nurse is preparing to give a medication to a child. The child's parent asks whether the drug is safe for children. How will the nurse respond to the parent?

Correct Answer is C

Explanation

What action does the nurse take during the intervention stage of the nursing process related to drug therapy?

Before marketing a new drug that has been approved for use based on clinical effectiveness and safety, the manufacturer wishes to study the potential new uses for the drug. This is an example of which phase of study?

The patient is taking low-dose aspirin daily for his heart. The nurse knows only a portion of the medication taken actually reaches the tissue due to what process?

In response to the patient's question about how to know whether drugs are safe, the nurse explains that all medications undergo rigorous scientific testing controlled by what organization?

The nurse, assisting with Phase I drug studies, is talking with a woman who asks, “Why can't I participate in this study”? What would be the nurse's best response?

Which are responsibilities of the FDA? (Select all that apply.)

A nurse is instructing a pregnant patient concerning the potential risk to her fetus from a Pregnancy Category B drug. The nurse would inform the patient that:

A clinical drug trial is conducting a study of pharmacokinetics and safety of a drug in healthy individuals. The nurse will assist enrollment of participants into the next phase of the study and will include which subject?